Hristina Yotova Hitkova

Hristina Yotova Hitkova

Auto-generated profile, based on publicly available information

Hristina Yotova Hitkova

Department of Microbiology and Virology, Medical University of Pleven, 5800 Pleven, Bulgaria

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 July 2024 in Catalysts
Verified
Journal Article
Open access
PDF file
ASAngelina Stoyanova
Angelina Stoyanova
HHHristina Hitkova
Hristina Hitkova
Nina KanevaNina Kaneva
Nina Kaneva
Albena Bachvarova-NedelchevaAlbena Bachvarova-Nedelcheva
Albena Bachvarova-Nedelcheva
RIReni S. Iordanova
Reni S. Iordanova
PMPolya Marinovska
Polya Marinovska
The current study aims to synthesize and analyze both pure and La-doped TiO2, and evaluate the photocatalytic and antibacterial activity of as-prepared samples. Doped and undoped samples were prepared by the non-hydrolytic sol–gel method from titanium(IV) chloride, benzyl alcohol, and lanthanum(III) nitrate followed by thermal treatment. Lanthanum content in synthesized samples was 0.4, 1, and 5 mol%. The resulting nanopowders’ structure and morphology were described using XRD, IR, and UV–Vis analysis. The average particle sizes of pure and doped TiO2 were about 6–15 nm and anatase was found to be a dominant crystalline phase in the samples. It was observed that particle sizes decreased on increasing La content. The photocatalytic activity of the pure and La-doped sol–gel powders was estimated in the decomposition of paracetamol in distilled water using ultraviolet light illumination. Doping with lanthanum ions has been shown to increase the photocatalytic properties on the degradation of paracetamol. Furthermore, the annealed catalysts (pure and La3+ doped) showed increased photocatalytic activity and degradation of the analgesic in comparison with non-annealed materials. In both cases, the highest photocatalytic efficiency is observed at the optimal La3+ (1 mol%) concentration. The antimicrobial activity of 1 mol% La/TiO2 was tested against a reference strain E. coli in the presence of ultraviolet light and in dark conditions. The number of viable bacterial cells was determined by a spread plate method, and kill curves were performed. The results showed that photoactivated 1 mol% La/TiO2 exhibited a strong bactericidal effect, and in concentration, 1 mg/mL efficiently killed bacteria at an initial cell density of about 105 colony forming units in 1 mL within 15 min.

1 December 2024 in Polish Journal of Microbiology
Verified
Journal Article
Open access
PDF file
Vasil S. BoyanovVasil S. Boyanov
Vasil S. Boyanov
AAAlexandra Alexandrova
Alexandra Alexandrova
PHPreslava Hristova
Preslava Hristova
HHHristina Y. Hitkova
Hristina Y. Hitkova
RGRaina Tzvetanova Gergova
Raina Tzvetanova Gergova
Streptococcus agalactiae ( group B Streptococcus , GBS) is an important human and animal pathogen. In recent years, the number of streptococcal isolates resistant to antimicrobial agents has increased in many parts of the world. Various mechanisms of antimicrobial resistance and capsular serotypes of GBS with different geographical distributions can be found. A prospective cross-sectional study was conducted from September 2021 to May 2024. The survey included 257 GBS isolates from Bulgarian inpatients and outpatients with streptococcal infections. Antibiotic resistance genes and capsular serotypes were detected and evaluated using polymerase chain reaction (PCR). We classified GBS isolates into groups according to their source as vaginal samples (191) and extra-vaginal samples (66), subdivided as invasive (36) and non-invasive specimens (30). The most common serotypes were Ia (26.5%), III (20.2%), and V (19.8%). Antimicrobial susceptibility testing revealed that all examined isolates were susceptible to penicillin and vancomycin. Resistance to macrolides, lincosamides, and tetracyclines was observed in 60.3%, 24.9%, and 89.1% of the isolates. The distribution of phenotypes was cMLSb 47.4%, iMLSb 30.8%, M-type 21.2%, and L-type 0.6%. PCR analysis revealed nine genes associated with macrolide and lincosamide resistance: ermB (54.2%), ermA / TR (30.3%), mefA (20.7%), ermC (18.1%), msrD (14.8%), mefE (8.4%), IsaC (8.4%), InuB (7.7%), and IsaE (6.5%). Two genes linked to tetracycline resistance tetM (89.1%) and tetO (14.4%) were detected. Compared to the previous period, we observed increased antibiotic resistance. There was no statistical significance between the distribution of serotypes and antimicrobial non-susceptibility depending on the sample source.

4 August 2025 in Microorganisms
Verified
Journal Article
Open access
PDF file
Teodora Vasileva Marinova-BulgaranovaTeodora Vasileva Marinova-Bulgaranova
Teodora Vasileva Marinova-Bulgaranova
HHHristina Yotova Hitkova
Hristina Yotova Hitkova
NBNikolay Kirilov Balgaranov
Nikolay Kirilov Balgaranov
Acinetobacter baumannii is one of the most challenging nosocomial pathogens associated with a variety of hospital infections, such as ventilator-associated pneumonia, wound and urinary tract infections, meningitis, and sepsis, primarily in patients treated in critical care settings. Its classification as a high-priority pathogen is due to the emergence of multidrug-resistant strains in healthcare environments and its tendency to spread clonally. A. baumannii belongs to the Acinetobacter calcoaceticus–Acinetobacter baumannii (Acb) complex, a group of genotypically and phenotypically similar species. Differentiating between the species is important because of their distinct clinical significance. However, conventional phenotypic methods, both manual and automated, often fail to provide accurate species-level identification. This review aims to summarize current phenotypic and genotypic methods for the identification of species within the Acb complex, evaluating their strengths and limitations to offer guidance for their appropriate application in diagnostic settings and epidemiological investigations.

17 January 2025 in Microorganisms
Verified
Journal Article
Open access
PDF file
Tanya StratevaTanya Strateva
Tanya Strateva
PHPreslava Hristova
Preslava Hristova
TSTemenuga Stoeva
Temenuga Stoeva
HHHristina Hitkova
Hristina Hitkova
SPSlavil Peykov
Slavil Peykov
Linezolid is an oxazolidinone antibiotic and is considered a last-resort treatment option for serious infections caused by problematic Gram-positive pathogens, including vancomycin-resistant enterococci. The present study aimed to explore the linezolid resistance mechanisms and genomic characteristics of two vancomycin-susceptible Enterococcus faecalis isolates from Bulgaria. The strains designated Efs2503-bg (inpatient from Pleven) and Efs966-bg (outpatient from Varna) were recovered from wounds in 2018 and 2023, respectively. Antimicrobial susceptibility testing, whole-genome sequencing, multilocus sequence typing, and phylogenomic analysis based on 332 linezolid-resistant E. faecalis genomes were performed. Efs2503-bg was high-level resistant to linezolid (MIC > 256 mg/L) and displayed the G2576T mutation affecting three of the four 23S rDNA loci. Efs966-bg (MIC = 8 mg/L) carried a plasmid-located optrA determinant surrounded by fexA and ermA. No mutations in the genes encoding for ribosomal proteins L3, L4, and L22 were detected. The isolates belonged to the sequence types ST6 (Efs2503-bg) and ST1102 (Efs966-bg). Phylogenomic analysis revealed that Efs2503-bg and Efs966-bg are genetically distinct, with a difference of 12,051 single-nucleotide polymorphisms. To our knowledge, this is the first report of linezolid-resistant enterococci in Bulgaria. Although the global incidence of linezolid-resistant enterococci is still low, their emergence is alarming and poses a growing clinical threat to public health.

5 August 2019 in Journal of IMAB – Annual Proceeding (Scientific Papers)
Verified
Journal Article
Open access
HHHristina Y. Hitkova
Hristina Y. Hitkova
PHPreslava Hristova
Preslava Hristova

Verified
Journal Article
Open access
PDF file
AAAlexandra Alexandrova
Alexandra Alexandrova
Vasil S. BoyanovVasil S. Boyanov
Vasil S. Boyanov
KMKalina Mihova
Kalina Mihova
PHPreslava Mihaylova Hristova
Preslava Mihaylova Hristova
HHHristina Y. Hitkova
Hristina Y. Hitkova
RGRaina Tzvetanova Gergova
Raina Tzvetanova Gergova
Streptococcus pneumoniae has been a PCV10 vaccine-preventable agent in Bulgaria since 2010. Our objective is to determine the phylogenetic structure of 170 invasive and non-invasive pneumococcal isolates, focusing on their serotypes and antimicrobial susceptibility. Serotyping was performed using latex agglutination, capsular swelling reaction, and serotype-specific PCRs. Antibiotic susceptibilities were assessed by broth microdilution. MLST was conducted to define the clonal composition. The non-PCV10 serotypes accounted for 88.2%. The predominant invasive pneumococcal disease (IPD) serotypes were 19A (39.3%), 19F (21.4%), 6C (10.7%), 7F (7.1%), and 3 (7.1%). The prevalent NIPD serotypes were 19A (18.3%), 6C (15.5%), 3 (10.6%), 15A (7.7%), and 6A (6.3%). The overall antimicrobial non-susceptibility rates were: benzylpenicillin (55.2%), ceftriaxone (15.2%), cefuroxime (35.8%), amoxicillin-clavulanic acid (38.8%), erythromycin (60.5%), clindamycin (57.0%), tetracycline (43.5%), trimethoprim-sulfamethoxazole (62.9%), and chloramphenicol (13.5%). The multidrug resistance (MDR) strains were 60.5%. The predominant clone CC320, represented 20.0% MDR 19A and 19F strains linked to Taiwan19F-14 and GPSC1. CC273/Greece6B-22 and CC386 accounted for 5.3% 6A and 6C isolates. Most serotype 3 isolates are associated with CC505, associated with Netherlands3-31 and GPSC12. Switching to a conjugate vaccine with broader serotype coverage could reduce the incidence of 19A, 6C, and 15A MDR S. pneumoniae clones in our country.